Skip to content
PICO Portalanswers from OpenAlex

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

PaperCitations, authors & open-access status

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial is a paper indexed in PICO Portal from OpenAlex.

How many citations does Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial have?

PICO Portalcitation count

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial has 163 citations in the OpenAlex counts PICO Portal stores.

When was Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial published?

PICO Portalyear

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial has 2020 year in the PICO Portal index.

What is the open-access status of Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial?

PICO Portaloa status

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial has green oa status in the PICO Portal index.

What is the DOI of Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial?

PICO Portaldoi

The DOI for Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial is on the source record.

What is the PMID of Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial?

PICO Portalpmid

The PMID for Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial is on the source record.

What is the OpenAlex record for Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial?

PICO Portalopenalex

The OpenAlex for Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial